A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment Loredana G. MarcuE. Yeoh Review 30 July 2009 Pages: 1303 - 1314
A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland Hong HeGuanfu ChenYanmin Liu Original Paper 26 March 2009 Pages: 1315 - 1321
Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer Wei-Qing XuLing-Jun SongGuo-Hui Fu Original Paper 28 March 2009 Pages: 1323 - 1330
Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance Guan Zhen YuYing ChenJie Jun Wang Original Paper 01 April 2009 Pages: 1331 - 1339
Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma Xiaoya YangGang XiongYun Bai Original Paper 08 April 2009 Pages: 1341 - 1349
B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? Petra RichterMarkus TostAlexander Berndt Original Paper 27 March 2009 Pages: 1351 - 1358
High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection Jie HuYang XuJian Zhou Original Paper 07 April 2009 Pages: 1359 - 1367
ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma Yao JinZhang Quan BinLan Qing Original Paper 02 April 2009 Pages: 1369 - 1376
Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo Michael PohlI. StrickerA. Reinacher-Schick Original Paper 02 April 2009 Pages: 1377 - 1386
Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma Günter EmonsRainer Kimmig Original Paper Open access 11 April 2009 Pages: 1387 - 1391
RETRACTED ARTICLE: Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer Xiao-Chun WangLi-Li TianAi-min Meng Original Paper 08 April 2009 Pages: 1393 - 1401
Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China Jia FanGuang-Shun YangJian-Jun Zhang Original Paper 21 April 2009 Pages: 1403 - 1412
Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications Hsi-Huang TsengJan-Gowth ChangHsin-Su Yu Original Paper 23 April 2009 Pages: 1413 - 1420
Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP Takeshi HaraHisashi TsurumiHisataka Moriwaki Original Paper 21 April 2009 Pages: 1421 - 1428
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy Stefan WilopSabine von HobeEdgar Jost Original Paper 28 April 2009 Pages: 1429 - 1435
A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma Chong ZhongRong-ping GuoYa-qi Zhang Original Paper 01 May 2009 Pages: 1437 - 1445
The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma Ning ZhangLu WangZhao-You Tang Original Paper 28 April 2009 Pages: 1447 - 1453
Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model Edwin HerrmannArne TiemannChristian Wülfing Original Paper 09 May 2009 Pages: 1455 - 1462
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations Per Arne AndresenKetil HeimdalTobias Gedde-Dahl Jr. Original Paper 15 May 2009 Pages: 1463 - 1470
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations Per Arne AndresenKetil HeimdalTobias Gedde-Dahl Jr. Erratum 30 June 2009 Pages: 1471 - 1471